Video

Patient Selection for Atopic Dermatitis Therapies

Author(s):

Raj Chovatiya, MD, PhD,Elizabeth Swanson, MD

Elizabeth A. Swanson, MD, provide insight on identifying the appropriate patients for various therapeutic regimens in atopic dermatitis.

Related Videos
Discussing 140-Week Data on Upadacitinib for Atopic Dermatitis, with Raj Chovatiya, MD, PhD
ADORING Trial Open-Label Extension: Tapinarof Cream 1% Results in Atopic Dermatitis
Linda Stein Gold, MD: Discussing New Phase 3b Data on Lebrikizumab for Atopic Dermatitis
New ‘Level Up’ Data on Upadacitinib (Rinvoq) for Atopic Dermatitis, with Christopher Bunick, MD, PhD
Shawn Kwatra, MD: Making the Connection Between Prurigo Nodularis, Atopic Dermatitis, and Itch
A panel of 3 experts on atopic dermatitis
Related Content
Peanut-Sensitized Infants with Eczema Already Co-Sensitized to Tree Nuts
November 20th 2024

Peanut-Sensitized Infants with Eczema Already Co-Sensitized to Tree Nuts

Tim Smith
Advances in Pediatric Eczema Highlight 2022
December 21st 2022

Advances in Pediatric Eczema Highlight 2022

Kevin Kunzmann
Ellen Sher, MD | Credit: Allergy Partners
November 11th 2024

Ellen Sher, MD: Cross-Specialty Collaboration Can Improve Atopic Dermatitis Management

Ellen Sher, MD Patrick Campbell
How Pegloticase Plus Methotrexate is Breaking Ground in Gout Care
July 12th 2022

How Pegloticase Plus Methotrexate is Breaking Ground in Gout Care

Armand Butera
Dupilumab for Atopic Dermatitis Sustained Efficacy in Clinical Signs, PROs Over 3 Years
November 11th 2024

Dupilumab for Atopic Dermatitis Sustained Efficacy in Clinical Signs, PROs Over 3 Years

Tim Smith
Global Biologic Access: Trends in 50 Countries Among Patients with Atopic Dermatitis
November 9th 2024

Global Biologic Access: Trends in 50 Countries Among Patients with Atopic Dermatitis

Tim Smith
© 2024 MJH Life Sciences

All rights reserved.